Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes Jan. 7, 2022
Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies Jan. 7, 2022
Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206 Jan. 7, 2022
RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies Jan. 7, 2022
RSS